Zhengye Biotechnology Holding (ZYBT) Receivables (2023 - 2024)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Zhengye Biotechnology Holding (ZYBT) has disclosed Receivables for 2 consecutive years, with $11.0 million as the latest value for Q4 2024.

• Quarterly Receivables rose 5.01% to $11.0 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $11.0 million through Dec 2024, up 5.01% year-over-year, with the annual reading at $11.0 million for FY2024, 3.04% up from the prior year.
• Receivables for Q4 2024 was $11.0 million at Zhengye Biotechnology Holding, up from $10.5 million in the prior quarter.
• The five-year high for Receivables was $11.0 million in Q4 2024, with the low at $10.5 million in Q4 2023.

Peer Comparison